参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Lee CM,Choi SH,Byun JH,et al.Combined computed tomography and magnetic resonance imaging improves diagnosis of hepatocellular carcinoma ≤ 3.0 cm[J].Hepatol Int,2021,15(3):676-684.[3]Lambin P,Rios-Velazquez E,Leijenaar R,et al.Radiomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.[4]Harding-Theobald E,Louissaint J,Maraj B,et al.Systematic review:radiomics for the diagnosis and prognosis of hepatocellular carcinoma[J].Aliment Pharmacol Ther,2021,54(7):890-901.[5]Mokrane FZ,Lu L,Vavasseur A,et al.Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules[J].Eur Radiol,2020,30(1):558-570.[6]Guo L,Li X,Zhang C,et al.Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: AMulti-Center Study[J].J Hepatocell Carcinoma,2023,10:795-806.[7]Mo ZY,Chen PY,Lin J,et al.Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation[J].Radiol Med,2023,128(3):261-273.[8]Feng M,Zhang M,Liu Y,et al.Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma:a retrospective study[J].BMC Cancer,2020,20(1):611-624.[9]Li HW,Yan GW,Yang J,et al.Quantitative analysis for detection and grading of hepatocellular carcinoma: Comparison of diffusion kurtosis imaging, intravoxel incoherent motion and conventional diffusion-weighted imaging[J].Oncol Lett,2022,24(5):403-417.[10]Mao Y,Wang J,Zhu Y,et al.Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma[J].Hepatobiliary Surg Nutr,2022,11(1):13-24.[11]Wu M,Tan H,Gao F,et al.Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature[J].Eur Radiol,2019,29(6):2802-2811.[12]Apte RS,Chen DS,Ferrara N.VEGF in Signaling and Disease: Beyond Discovery and Development[J].Cell,2019,7(6):1248-1264.[13]Zhang H,Liu R,Sun L,et al.A Reliable Prognostic Model for HCC Using Histological Grades and the Expression Levels of Related Genes[J].J Oncol,2021,7(3):951-967.[14]中华人民共和国国家卫生健康委员会.原发性肝癌诊疗指南(2022年版)[J].肿瘤防治研究,2022,49(3):251-276.[15]Hu HT,Wang Z,Kuang M,et al.Need for normalization:the non-standard reference standard for microvascular invasion diagnosis in hepatocellular carcinoma[J].World J Surg Oncol,2018,16(1):50-65.[16]Rhee H,An C,Kim HY,et al.Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement:MoreAggressive Pathologic Features[J].Liver Cancer,2019,8(1):24-40.[17]Qu C,Wang Q,Li C,et al.A Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma ≤ 5 cm[J].Front Oncol,2022,19(4):76-89. [18]Yang L,Gu D,Wei J,et al.A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma[J].Liver Cancer,2019,8(5):373-386.[19]Alabed S,Saunders L,Garg P,et al.Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension:A systematic review and meta-analysis[J].Magn Reson Imaging,2021,79(2):66-75. [20]Kaolawanich Y,Azevedo CF,Kim HW,et al.Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction[J].JACC Cardiovasc Imaging,2022,15(12):2069-2079.[21]Moulin K,Viallon M,Romero W,et al.MRI of Reperfused Acute Myocardial Infarction Edema:ADC Quantification versus T1 and T2 Mapping[J].Radiology,2020,295(3):542-549.[22]Bi XJ,Zhang XQ,Zhang T,et al.Quantitative assessment of liver function with hepatocyte fraction: Comparison with T1 relaxation-based indices[J].Eur J Radiol,2021,141(6):104-119.[23]Yang P,Si A,Yang J,et al.A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion[J].Surgery,2019,165(4):721-730.[24]Chen S,Wang C,Gu Y,et al.Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses[J].Front Oncol,2022,14(11):774-790.[25]Hwang YJ,Bae JS,Lee Y,et al.Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging[J].Clin Mol Hepatol,2023,29(3):733-746.[26]古今,张瑜,周泽芬,等.基于术前超声影像组学特征的粗梁-团块型肝细胞癌区分模型的构建及其应用[J].临床超声医学杂志,2022,24(8):578-582.[27]Ziol M,Poté N,Amaddeo G,et al.Macrotrabecular-massive hepatocellular carcinoma:A distinctive histological subtype with clinical relevance[J].Hepatology,2018,68(1):103-112.[28]Zhang Y,He D,Liu J,et al.Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics[J].World J Gastroenterol,2023,29(13):2001-2014. [29]Feng Z,Li H,Zhao H,et al.Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma[J].Radiology,2021,300(1):219-229.[30]Li X,Yao Q,Liu C,et al.Macrotrabecular-Massive Hepatocellular Carcinoma:What Should We Know?[J].Hepatocell Carcinoma,2022,5(9):379-387.[31]Tang Q,Su Z,Gu W,et al.Mutant p53 on the Path to Metastasis[J].Trends Cancer,2020,6(1):62-73.[32]Zhou HC,Liu CX,Pan WD,et al.Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma[J].J Hepatol,2021,75(4):900-911.[33]Akiba J,Nakayama M,Sadashima E,et al.Prognostic impact of vessels encapsulating tumor clusters and macrotrabecular patterns in hepatocellular carcinoma[J].Pathol Res Pract,2022,238(10):154-169.[34]Vanderborght B,Lefere S,Vlierberghe HV,et al.The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma[J].Cells,2020,9(11):23-34.[35]Rastogi A,Maiwall R,Ramakrishna G,et al.Hepatocellular carcinoma:Clinicopathologic associations amidst marked phenotypic heterogeneity[J].Pathol Res Pract,2021,217(6):153-168.[36]Remnant L,Kochanova NY,Reid C,et al.The intrinsically disorderly story of Ki-67[J].Open Biol,2021,11(8):210120.[37]Hu X,Zhou J,Li Y,et al.Added Value of Viscoelasticity for MRI-Based Prediction of Ki-67 Expression of Hepatocellular Carcinoma Using a Deep Learning Combined Radiomics (DLCR) Model[J].Cancers (Basel),2022,14(11):25-38.[38]Shahryari M,Tzsch?覿tzsch H,Guo J,et al.Tomoelastography Distinguishes Noninvasively between Benign and Malignant Liver Lesions[J].Cancer Res,2019,79(22):5704-5710.[39]Yan Y,Lin XS,Ming WZ,et al.Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma[J].Acad Radiol,2024,31(3):859-869.[40]Mitchell KG,Parra ER,Nelson DB,et al.Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer[J].J Thorac Cardiovasc Surg,2019,158(3):911-919.[41]Spyratou V,Freyhult E,Bergh A,et al.Ki67 and prostate specific antigen are prognostic in metastatic hormone na?觙ve prostate cancer[J].Acta Oncol,2023,62(12):1698-1706.[42]Lashen A,Toss MS,Green AR,et al.Ki67 assessment in invasive luminal breast cancer:a comparative study between different scoring methods[J].Histopathology,2022,81(6):786-798.[43]Yang X,Ni H,Lu Z,et al.Mesenchymal circulating tumor cells and Ki67:their mutual correlation and prognostic implications in hepatocellular carcinoma[J].BMC Cancer,2023,23(1):10-22.[44]Hemida AS,Taie DM,El-Wahed MMA,et al.EpCAM, Ki67,and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation[J].Appl Immunohistochem Mol Morphol,2023,31(9):596-606.[45]Yang C,Zhang J,Ding M,et al.Ki67 targeted strategies for cancer therapy[J].Clin Transl Oncol,2018,20(5):570-575.
相似文献/References:
[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及
肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(06):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(06):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[3]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Journal of Medical Information,2020,33(06):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
[4]孙莹莹,龚先琼.中药单体治疗肝细胞癌的研究[J].医学信息,2021,34(09):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
SUN Ying-ying,GONG Xian-qiong.Study on the Treatment of Hepatocellular Carcinoma with Chinese Medicine Monomer[J].Journal of Medical Information,2021,34(06):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
[5]林思其,张泽鑫,夏睿琪,等.三种miRNA对肝癌预后预测的生物信息学分析模型[J].医学信息,2022,35(03):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
LIN Si-qi,ZHANG Ze-xin,XIA Rui-qi,et al.A Model of Three miRNA on the Prognosis Prediction of Hepatocellular Carcinomaby Bioinformatics Analysis[J].Journal of Medical Information,2022,35(06):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
[6]李一鸣,陈文翔,王 禹,等.肝癌预后模型的构建及其在免疫治疗中的作用研究[J].医学信息,2022,35(04):68.[doi:10.3969/j.issn.1006-1959.2022.04.018]
LI Yi-ming,CHEN Wen-xiang,WANG Yu,et al.The Construction of a Prognostic Model for Hepatocellular Carcinomaand its Role in Immunotherapy[J].Journal of Medical Information,2022,35(06):68.[doi:10.3969/j.issn.1006-1959.2022.04.018]
[7]徐帅帅,高 斌.TACE与阿帕替尼联合治疗中晚期肝细胞癌的疗效及安全性分析[J].医学信息,2022,35(06):116.[doi:10.3969/j.issn.1006-1959.2022.06.028]
XU Shuai-shuai,GAO Bin.Analysis of the Efficacy and Safety of TACE Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(06):116.[doi:10.3969/j.issn.1006-1959.2022.06.028]
[8]滕璐心,安云翔,黄 煜.MRI评价胆管内乳头状肿瘤侵袭性的价值[J].医学信息,2022,35(14):138.[doi:10.3969/j.issn.1006-1959.2022.14.035]
TENG Lu-xin,AN Yun-xiang,HUANG Yu.The Value of MRI in Evaluating the Invasiveness of Intraductal Papillary Tumors[J].Journal of Medical Information,2022,35(06):138.[doi:10.3969/j.issn.1006-1959.2022.14.035]
[9]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Journal of Medical Information,2022,35(06):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
[10]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(06):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]